Welcome to our dedicated page for CoreWeave SEC filings (Ticker: CRWV), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The CoreWeave, Inc. (Nasdaq: CRWV) SEC filings page provides access to the company’s regulatory disclosures, including current reports on Form 8-K and other key documents filed with the U.S. Securities and Exchange Commission. As a publicly traded Software - Infrastructure company focused on AI cloud services, CoreWeave uses its filings to describe material agreements, financing arrangements, and significant corporate events.
In its Form 8-K filings, CoreWeave has reported material definitive agreements such as master services agreements and order forms with OpenAI, Meta Platforms, Inc., and NVIDIA Corporation, which govern access to cloud computing capacity and reserved capacity arrangements. The company has also disclosed credit agreements and delayed draw term loan facilities used to finance capital expenditures for GPU servers, infrastructure, and systems that support strategic customer contracts.
CoreWeave’s filings include detailed descriptions of its debt and capital structure, such as senior notes, revolving credit facilities, and convertible senior notes due 2031. These documents outline terms like interest rates, maturity dates, conversion features, capped call transactions, guarantees by subsidiaries, and financial covenants. Investors can review these filings to understand how CoreWeave funds its AI infrastructure and manages potential dilution.
Other 8-K filings cover topics such as the termination of a proposed merger agreement, changes in classification of equity related to preferred stock put rights, and the registration of Class A common stock on The Nasdaq Stock Market LLC under the symbol CRWV. Results of operations and financial condition for specific quarters are also furnished via 8-K exhibits.
On Stock Titan, AI-powered tools can help summarize lengthy CoreWeave filings, highlight key terms in documents like credit agreements and indentures, and surface information on topics such as material customer contracts, new financing facilities, and significant corporate events. Users can quickly locate references to items like convertible notes, capped call transactions, or major AI infrastructure commitments without reading every page.
CRWV reports proposed sales of Common Stock by affiliated holders and other holders.
The excerpt lists multiple planned or completed 10b5-1 sales attributed to Michael Intrator and OMNADORA CAPITAL LLC on dates in 2025–2026, plus a listed sale by Fidelity Charitable on 03/05/2026 of 86,710 shares for $6,449,923.35. The entries show per-transaction share counts and dollar amounts tied to specific sale dates.
CRWV reported multiple sell transactions executed under 10b5-1 plans for common stock. The filing lists numerous trustee and trust sales across dates in December 2025 through March 2026, including large recurring blocks such as 102,835 and 303,929 shares reported on specific trade dates.
The notice names several selling entities (trusts and charitable accounts) and shows per-trade share counts and gross proceeds. These are routine plan-based dispositions reported on Form 144, not an issuance by the company.
Morgan Stanley Smith Barney LLC submitted a Form 144 reporting proposed sales of common shares by multiple affiliated trusts and holders under 10b5-1 plans. The filing lists repeated sale entries (including 25,000-share and 102,830–102,835-share line items) with dates from 12/15/2025 through 03/05/2026.
Filer submitted Regulation 144 notices reporting multiple planned or executed 10b5-1 sales of common stock by several trusts and holders. Examples include Fidelity Charitable selling 303,929 shares on 03/05/2026 for $22,930,105.76, and multiple scheduled sales by trust accounts such as Brannin-related entities.
CRWV Rule 144 notice listing proposed sales of common shares by affiliated holders and trusts. The filing lists multiple 10b5-1 program sales and scheduled lots across December 2025–March 2026, including repeated entries of 102,835 and 25,000 share sales and numerous 500-share lots. Specific dates and per-holder share amounts are provided for each sale.
CRWV related parties filed a Form 144 notice reporting a proposed sale of 300,000 Founders Shares.
The filing lists 300,000 shares and an aggregate figure of $21,897,000.00, with Morgan Stanley Smith Barney LLC shown as broker and 03/09/2026 noted on the report.
CoreWeave, Inc. director and Chief Strategy Officer Brian M. Venturo reported transactions on Class A and Class B shares through related entities. West Clay Capital LLC, of which he is managing member, converted 281,250 Class B shares into 281,250 Class A shares at $0.00 per share via derivative conversion.
West Clay Capital LLC then sold an aggregate of 281,250 Class A shares in multiple open‑market transactions at weighted‑average prices of about $76.41 to $80.22 per share under a Rule 10b5‑1 trading plan adopted on May 21, 2025. Following these moves, Venturo also reported ongoing direct and indirect holdings of Class A and Class B shares through himself, West Clay Capital LLC, several family trusts, and his spouse and father‑in‑law.
CoreWeave, Inc.’s Chief Financial Officer, Nitin Agrawal, sold 3,920 shares of Class A Common Stock in open-market transactions. The sales occurred on March 3, 2026 at prices ranging from $70.67 to $75.00, based on weighted average prices disclosed in the filing.
The transactions were executed under a pre-established Rule 10b5-1 trading plan adopted on May 22, 2025. After the direct sales, Agrawal held 169,185 shares directly, and additional shares were reported as held indirectly through a spouse and two 2025 GRAT trusts.
CRWV-related holders reported planned and executed sales of common stock under Rule 144 and 10b5-1 plans. The notice lists multiple 10b5-1 sales by WEST CLAY CAPITAL LLC and transactions by Brian Venturo, including 281,250 shares on 02/18/2026 and 52,473 shares on 01/06/2026.
CRWV insider transactions were reported via Rule 144 notices showing planned or completed sales of common stock. The filing lists sales by Nitin Agrawal on 12/11/2025 (66,467 shares for $5,488,532.47), 12/16/2025 (36,317 shares for $2,512,275.69), and 02/20/2026 (5,383 shares for $488,979.97). The broker identified is Morgan Stanley Smith Barney LLC.